Pennsylvania

Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 17, 2019 /PRNewswire/ -- A new interim analysis of three-year data from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) real-world study on effectiveness shows that Jardiance® (empagliflozin) was…
Continue Reading »
Pennsylvania

Mezzion Pharma announces the presentation of the FUEL Trial data at the American Heart Association Meeting in Philadelphia

DEERFIELD, Ill., Nov. 17, 2019 /PRNewswire/ -- Mezzion Pharma Co. Ltd. (140410: KOSDAQ) today announces the presentation of data from its pivotal clinical trial for its new orphan drug for…
Continue Reading »
Pennsylvania

Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack

THOUSAND OAKS, Calif., Nov. 16, 2019 /PRNewswire/ -- Amgen today announced a new analysis from the Repatha® (evolocumab) cardiovascular outcomes (FOURIER) study that evaluates the effectiveness of Repatha in patients who…
Continue Reading »
Pennsylvania

Centric Bank CEO Patti Husic Honored with 2019 Lifetime Achievement Award at The Conference for Women

HARRISBURG, Pa., Nov. 15, 2019 /PRNewswire/ -- Patricia (Patti) A. Husic, President and CEO of Centric Bank and Centric Financial Corporation, has been named winner of the Lifetime Achievement Award at The…
Continue Reading »